EPS Holdings Inc (4282):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:EPS Holdings Inc (4282) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8039
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EPS Holdings Inc (EPS) is a pharmaceutical solutions provider to the healthcare industry. The company provides contract research organization, site management organization, contract sales organization, and other related services for pharmaceutical and medical device development. Its services include business analysis, CDISC standard service, drug development support services, education and training, generic drug development services, and medical device development support services. EPS provides services for clinical researches to obtain quality data and reliable results, including planning, implementation, data processing and management, statistical analysis, reporting the results, and others. The company has operations in Fujimi, Kofu, Nagoya, Osaka, and Tokyo. EPS is headquartered in Tokyo, Japan.

EPS Holdings Inc (4282) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EPS Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EPS Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Hangzhou Tigermed Consulting Enters into Agreement with EPS Holdings 11
EPS Forms Joint Venture With GNI Group 12
Equity Offering 13
EPS Holdings to Raise USD405 Million in Private Placement of Shares 13
Acquisition 14
EPS to Acquire Sogo Rinsho Holdings 14
EPS To Acquire JGC Pharma Services From JGC Corp For US$11 Million 15
EPS Acquires GleneaglesCRC From Parkway Holdings And Mitsui 16
EPS Holdings Inc – Key Competitors 17
EPS Holdings Inc – Key Employees 18
EPS Holdings Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
EPS Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EPS Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EPS Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 8
EPS Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hangzhou Tigermed Consulting Enters into Agreement with EPS Holdings 11
EPS Forms Joint Venture With GNI Group 12
EPS Holdings to Raise USD405 Million in Private Placement of Shares 13
EPS to Acquire Sogo Rinsho Holdings 14
EPS To Acquire JGC Pharma Services From JGC Corp For US$11 Million 15
EPS Acquires GleneaglesCRC From Parkway Holdings And Mitsui 16
EPS Holdings Inc, Key Competitors 17
EPS Holdings Inc, Key Employees 18
EPS Holdings Inc, Subsidiaries 19
EPS Holdings Inc, Joint Venture 19

List of Figures
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EPS Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EPS Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[EPS Holdings Inc (4282):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BCD Travel Services B.V.:企業の戦略・SWOT・財務情報
    BCD Travel Services B.V. - Strategy, SWOT and Corporate Finance Report Summary BCD Travel Services B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cboe Global Markets, Inc (CBOE):企業の財務・戦略的SWOT分析
    Cboe Global Markets, Inc (CBOE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Broadcom Inc:企業の戦略・SWOT・財務情報
    Broadcom Inc - Strategy, SWOT and Corporate Finance Report Summary Broadcom Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • MAXIMUS Inc (MMS):企業の財務・戦略的SWOT分析
    MAXIMUS Inc (MMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Dynasil Corporation of America (DYSL):企業の財務・戦略的SWOT分析
    Summary Dynasil Corporation of America (Dynasil) is an electronic equipment company that develops and manufactures optics and photonics products. The company’s products include beam splitters, bandpass filters, coatings, crystal materials, imaging detectors, diffraction gratings, tunable light sourc …
  • W.O.M. World of Medicine GmbH:企業の戦略的SWOT分析
    W.O.M. World of Medicine GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Electro Scientific Industries Inc (ESIO):企業の財務・戦略的SWOT分析
    Summary Electro Scientific Industries Inc (ESI) is a technology company that offers laser-based manufacturing solutions. The company offers products such as flex interconnect, circuit packaging, high density interconnect, automation, scribbing and grooving, memory repair, wafer marking, laser ablati …
  • Hunter Oil Corp (HOC):石油・ガス:M&Aディール及び事業提携情報
    Summary Hunter Oil Corp (HOC), formerly Enhanced Oil Resources Inc is an oil and gas company that offers energy production programs. The company offers production and rehabilitation of its legacy oil fields through full cycle development. It also provides full cycle development services such as rese …
  • Hosken Consolidated Investments Ltd (HCI):企業の財務・戦略的SWOT分析
    Hosken Consolidated Investments Ltd (HCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Medical University of Vienna-製薬・医療分野:企業M&A・提携分析
    Summary Medical University of Vienna (MUV) is a medical research institute that offers educational services. The institute provides research and education services in the field of medical science. Its research services include project submission, clinical and preclinical studies, research funding, b …
  • Northern Trust Corporation:企業のM&A・事業提携・投資動向
    Northern Trust Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Northern Trust Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • LIG Nex1 Co Ltd:企業の戦略・SWOT・財務分析
    LIG Nex1 Co Ltd - Strategy, SWOT and Corporate Finance Report Summary LIG Nex1 Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Granules India Ltd (GRANULES):製薬・医療:M&Aディール及び事業提携情報
    Summary Granules India Ltd (Granules) is a pharmaceutical manufacturing company, which carries out the research, development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs). The company manufactures Paracetomol, …
  • Anthem Inc (ANTM)-製薬・医療分野:企業M&A・提携分析
    Summary Anthem Inc (Anthem), formerly WellPoint Inc, is a health benefits company. It offers several managed healthcare related products and related administrative services. It also provides various specialty and insurance products and services including radiology benefit management, dental, life an …
  • Pacira BioSciences Inc (PCRX):企業の財務・戦略的SWOT分析
    Pacira BioSciences Inc (PCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Axikin Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Axikin Pharmaceuticals Inc (Axikin) is a biopharmaceutical company that develops small molecule therapeutics for respiratory disorders. The company offers pre-clinical and research programs with small molecule therapeutics for applications in asthma, chronic obstructive pulmonary disease, in …
  • Green Cross Cell Corp (031390)-製薬・医療分野:企業M&A・提携分析
    Summary Green Cross Cell Corp (Green Cross Cell), formerly Innocell Corp, a subsidiary of Green Cross Corp, is a provider of immunotherapeutics for the treatment of cancer. The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient. It offer …
  • ReShape Medical Inc-製薬・医療分野:企業M&A・提携分析
    Summary ReShape Medical Inc (ReShape Medical) is a medical device company that offers weight loss solutions. The company provides dual intragastric balloon for weight loss. Its product comprises of ReShape Duo, a non surgical dual-intragastric balloon used in the treatment of obese or overweight pat …
  • PledPharma AB (PLED):企業の財務・戦略的SWOT分析
    Summary PledPharma AB (PledPharma) is a pharmaceutical company that discovers, manufactures, and develops drugs that protect the body against oxidative stress. The company discovers and develops Aladote and PledOx drugs. PledOX drug is used to prevent chemotherapy-induced side effects for colorectal …
  • Innoviva Inc (INVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Innoviva Inc (Innoviva) develops and commercializes small molecule medicines. It focuses on products for various respiratory disorders. The company partners with GSK for the commercialization and development of all its products. It receives royalty payments for its collaboration with GSK. In …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆